"[T]he provisions of [Executive Order 14273] appear intended to drive down the prices that the federal government pays for drugs and reduce out-of-pocket costs for patients, with many provisions designed to do both.... [P]rivate payors are also targeted through efforts to increase transparency in their compensation models."  MORE >>